Tuesday, January 28, 2014
AbbVie – A Dividend Supplement for Your Portfolio
AbbVie (ABBV), a research-based pharmaceuticals company that was spun off by Abbott Laboratories (ABT), was listed on the New York Stock Exchange in January 2013. The company hit the stock markets running, as the separation of AbbVie and Abbott had unlocked significant shareholder value. Its stock rose 8% in its first month of trading, while the S&P 500 rose 5% in the same period. It continued gaining ground through the year, closing 2013 up 54.6%, compared to the S&P 500’s gain of 29.6%.
We feel 2014 promises to another good year for the company, as it is expected to introduce new products that will boost topline growth. The company has so far paid a constant dividend of $0.40, and its stock has a dividend yield of 3.16%; however, if its parent’s history is anything to go by, it is likely to increase payouts this year, and dividend investors should be taking note.
Read More : ABBV - ABT